Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 2/20 | 0.58 |
| ▸ | DDO | Q99489 | 1/20 | 0.58 |
| ▸ | SMYD3 | Q9H7B4 | 2/20 | 0.55 |
| ▸ | BRD4 | O60885 | 1/20 | 0.53 |
| ▸ | PADI4 | Q9UM07 | 2/20 | 0.50 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.50 |
| ▸ | KDR | P35968 | 1/20 | 0.50 |
| ▸ | FLT3 | P36888 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.47 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.47 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.47 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29390425 | 1.00 | DAO (0.58) | DAODDOSMYD3BRD4PADI4 | |
| Hydrochloric Acid SCHEMBL30321479 | 0.98 | DAO (0.56) | DAODDOSMYD3BRD4PADI4 | |
| Pyrrole SCHEMBL6891936 | 0.92 | DAO (0.50) | DAODDOSMYD3BRD4PADI4 | |
| SCHEMBL1367711 | 0.85 | DAO (0.61) | DAODDOSMYD3BRD4PADI4 | |
| SCHEMBL19144385 | 0.84 | DAO (0.56) | DAODDOSMYD3BRD4PADI4 | |
| SCHEMBL5469228 | 0.84 | DAO (0.56) | DAODDOSMYD3BRD4PADI4 | |
| SCHEMBL31394 | 0.84 | KDM4E (0.59) | DAODDOSMYD3BRD4PADI4 | |
| SCHEMBL29364659 | 0.84 | KDM4E (0.59) | DAODDOSMYD3BRD4PADI4 | |
| SCHEMBL16627746 | 0.82 | DAO (0.58) | DAODDOSMYD3BRD4PADI4 | |
| Hydrochloric Acid SCHEMBL5027809 | 0.82 | KDM4E (0.58) | DAODDOSMYD3BRD4PADI4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 235 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260124198-A1 | ANTIVIRAL PYRAZOLOPYRIDINONE COMPOUNDS | GILEAD SCIENCES INC (US) | 2026-05-07 | — | — | US | claimed |
| EP-2609083-B1 | SUBSTITUTED 2-OXY-QUINOLINE-3-CARBOXAMIDES AS KCNQ2/3 MODULATORS | GRUENENTHAL GMBH (DE) | 2015-02-25 | — | — | EP | claimed |
| EP-2627638-A1 | 1,2-DIHYDRO-4-HYDROXY-2-OXO-QUINOLINE-3-CARBOXANILIDES AS AHR ACTIVATORS. | Immunahr AB (SE) | 2013-08-21 | — | — | EP | claimed |
| EP-2507225-A1 | L -DIHYDRO-2-OXOQUINOLINE COMPOUNDS A 5-HT4 RECEPTOR LIGANDS | Suven Life Sciences Limited (IN) | 2012-10-10 | — | — | EP | claimed |
| WO-2012050500-A1 | 1,2-DIHYDRO-4-HYDROXY-2-OXO-QUINOLINE-3-CARBOXANILIDES AS AHR ACTIVATORS. | PETTERSSON LARS (SE) | 2012-04-19 | — | — | WO | claimed |
| WO-2011030349-A1 | L -DIHYDRO-2-OXOQUINOLINE COMPOUNDS A 5-HT4 RECEPTOR LIGANDS | SUVEN LIFE SCIENCES LIMITED (IN) | 2011-03-17 | — | — | WO | claimed |
| US-20260124198-A1 | ANTIVIRAL PYRAZOLOPYRIDINONE COMPOUNDS | GILEAD SCIENCES INC (US) | 2026-05-07 | — | — | US | disclosed |
| CN-121574131-A | Heterocyclic compounds for insect repellent | 勃林格殷格翰动物保健有限公司 | 2026-02-27 | — | — | CN | disclosed |
| US-12559503-B2 | Anthelmintic aza-benzothiophene and aza-benzofuran compounds | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2026-02-24 | — | — | US | disclosed |
| EP-4661870-A1 | COMBINATIONS OF DGK (DIACYLGLYCEROL KINASE) INHIBITORS | Bayer Aktiengesellschaft (DE) | 2025-12-17 | — | — | EP | disclosed |
| EP-4582448-A2 | S100 PROTEINS AS NOVEL THERAPEUTIC TARGETS IN MYELOPROLIFERATIVE NEOPLASMS | Erasmus University Rotterdam Medical Center (NL) | 2025-07-09 | — | — | EP | disclosed |
| US-12312356-B2 | Anthelmintic heterocyclic compounds | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2025-05-27 | — | — | US | disclosed |
| EP-4185292-B1 | S100 PROTEINS AS NOVEL THERAPEUTIC TARGETS IN MYELOPROLIFERATIVE NEOPLASMS | UNIV ERASMUS MED CT ROTTERDAM (NL) | 2025-05-21 | — | — | EP | disclosed |
| US-5622967-A | NERVOUS SYSTEM DISORDERS | STERLING WINTHROP, INC. (US) | 1997-04-22 | — | — | US | disclosed |
| WO-1997004775-A1 | QUINOLONES AND THEIR THERAPEUTIC USE | CHIROSCIENCE LIMITED (GB) | 1997-02-13 | — | — | WO | disclosed |
| WO-1997004775-A1 | QUINOLONES AND THEIR THERAPEUTIC USE | CHIROSCIENCE LIMITED (GB) | 1997-02-13 | — | — | WO | disclosed |
| WO-1997004779-A1 | QUINOLONES AND THEIR THERAPEUTIC USE | CHIROSCIENCE LIMITED (GB) | 1997-02-13 | — | — | WO | disclosed |
| EP-0446604-A2 | Pyridine and related aza heterocycle derivatives as cardiovascular agents | AMERICAN CYANAMID COMPANY (US) | 1991-09-18 | — | — | EP | disclosed |
| US-4959363-A | HERPES VIRUS | STERLING DRUG INC. (US) | 1990-09-25 | — | — | US | disclosed |
| US-4284768-A | 1,2-Dihydro-4-amino-2-oxo-3-quinoline-carboxylic acid derivatives | AMERICAN HOME PRODUCTS CORPORATION (US) | 1981-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260124198-A1 | ANTIVIRAL PYRAZOLOPYRIDINONE COMPOUNDS | ZC3HAV1, CCR1, CCR6 | DAO 1055/4885DDO 1595/4885SMYD3 957/4885 |
| US-12312356-B2 | Anthelmintic heterocyclic compounds | AADAC, HNMT, HRH4 | DAO 1165/4885DDO 1816/4885SMYD3 237/4885 |
| US-12559503-B2 | Anthelmintic aza-benzothiophene and aza-benzofuran compounds | HDAC5, NR5A2, HRH4 | DAO 287/4885DDO 437/4885SMYD3 1470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.